Clinical Trial Update: Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Latrepirdine (DMB-I) in Alzheimer’s-type dementia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Latrepirdine (latrepirdine)

Snippet

Sponsor: Bigespas LTD | Conditions: Alzheimer Type Dementia | Phase 3 | Status: RECRUITING